Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma
Deming Duan, Keke Wang, Wei Cheng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 204
Next generations of CAR-T cells - new therapeutic opportunities in hematology?
Jaromir Tomasik, Marcin Jasiński, Grzegorz Basak
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 667-686
Open Access | Times Cited: 44
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
Lin Tang, Sheng Pan, Xuyong Wei, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3146-3162
Open Access | Times Cited: 43
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies
Zhengzheng Zhang, Tian Wang, Xiaofeng Wang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106036-106036
Open Access | Times Cited: 70
IL-7: Comprehensive review
Hila Winer, Gisele Rodrigues, Julie A. Hixon, et al.
Cytokine (2022) Vol. 160, pp. 156049-156049
Closed Access | Times Cited: 62
Cytokines as an important player in the context of CAR-T cell therapy for cancer: Their role in tumor immunomodulation, manufacture, and clinical implications
Caio Raony Farina Silveira, Amanda Cristina Corveloni, Sâmia Rigotto Caruso, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
Alain E. Andrea, Andrada Chiron, Sarah Mallah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
David Kegyes, Cătălin Constantinescu, Louise Vrancken, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 43
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 22
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 10
Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies
Yugu Zhang, Diyuan Qin, Arthur Shou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6124-6124
Open Access | Times Cited: 17
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 3-24
Closed Access | Times Cited: 17
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Pengfei Zhang, Dan Xie
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
Maria Florencia Giraudo, Zachary Jackson, Indrani Das, et al.
Pathogens and Immunity (2024) Vol. 9, Iss. 1, pp. 1-17
Open Access | Times Cited: 7
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)
Jun Du, Lin Zheng, Xue-Hang Fu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Advances in IL-7 Research on Tumour Therapy
Chunxue Fu, Xinqiang Zhang, Xinyu Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 415-415
Open Access | Times Cited: 6
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review
Bibhu Prasad Satapathy, Pooja Sheoran, Rohit Yadav, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy
Maryam Sahlolbei, Amirhossein Ahmadieh-Yazdi, Mohadeseh Rostamipoor, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 5
Advance in chimeric antigen receptor T therapy in autoimmune diseases
Xiaolan Ji, Yunfan Sun, Yuyang Xie, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CAR-T therapy dilemma and innovative design strategies for next generation
Zhiwei Wang, Peixian Li, Xiaoyu Zeng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Targeting integrins in drug‐resistant acute myeloid leukaemia
Heather Ogana, Samantha Hurwitz, Nathan Wei, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 295-316
Open Access | Times Cited: 12
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top